Modeling vitamin D actions in triple negative/basal-like breast cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 144, Issue PART A, 2014, Pages 65-73

  Laporta, Erika ^a   Welsh, Joellen ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Breast cancer; Invasion; Microarrays; Vitamin D

Indexed keywords

CALCITRIOL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; VITAMIN D RECEPTOR; ESTROGEN; SEOCALCITOL;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BASAL LIKE BREAST CANCER; BREAST CANCER CELL LINE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLONAL CELL LINE; COHORT ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REPRESSION; GENOMICS; HAS2 GENE; HBEGF GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PLAU GENE; POSTN GENE; PROTEIN FOLDING; STABLE EXPRESSION; TRIPLE NEGATIVE BREAST CANCER; TUMOR GENE; TUMOR INVASION; WESTERN BLOTTING; CANCER RECURRENCE; CELL CLONE; FEMALE; GENE EXPRESSION; PREVALENCE; PROTEIN EXPRESSION; REVIEW; TREATMENT OUTCOME; VITAMIN D DEFICIENCY;

MUS;

BREAST CANCER; INVASION; MICROARRAYS; VITAMIN D;

ANIMALS; CARCINOMA, BASAL CELL; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MODELS, BIOLOGICAL; TRIPLE NEGATIVE BREAST NEOPLASMS; VITAMIN D; VITAMINS;

EID: 84906790657     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2013.10.022     Document Type: Review

References (50)

1. M.O. Idowu, M. Kmieciak, and C. Dumur et al. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome Human Pathology 43 3 2012 364 373
2. Cancer Genome Atlas Network Comprehensive molecular portraits of human breast tumours Nature 490 7418 2012 61 70
3. J. Welsh Vitamin D and cancer: integration of cellular biology, molecular mechanisms and animal models Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum 243 2012 103 111
4. J.Y. So, A.K. Smolarek, and D.M. Salerno et al. Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancer PLoS ONE 8 1 2013 e54020
5. J.Y. So, H.J. Lee, and A.K. Smolarek et al. A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer Molecular Pharmacology 79 3 2011 360 367
6. L. Flanagan, K. Packman, B. Juba, S. O'Neill, M. Tenniswood, and J. Welsh Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion Journal of Steroid Biochemistry and Molecular Biology 84 2-3 2003 181 192
7. N.D. Mineva, X. Wang, and S. Yang et al. Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation Journal of Cellular Physiology 220 3 2009 593 599
8. D.A. Grotsky, I. Gonzalez-Suarez, and A. Novell et al. BRCA1 loss activates cathepsin l-mediated degradation of 53BP1 in breast cancer cells Journal of Cell Biology 200 2 2013 187 202
9. N. Lopes, J. Carvalho, and C. Duraes et al. 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation Anticancer Research 32 1 2012 249 257
10. L.L. Ooi, H. Zhou, and R. Kalak et al. Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis Cancer Research 70 5 2010 1835 1844
11. L.J. Peppone, A.S. Rickles, M.C. Janelsins, M.R. Insalaco, and K.A. Skinner The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels Annals of Surgical Oncology 19 8 2012 2590 2599
12. C. Rainville, Y. Khan, and G. Tisman Triple negative breast cancer patients presenting with low serum vitamin D levels: A case series Cases Journal 2 2009 8390
13. G.M. Zinser, K. McEleney, and J. Welsh Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice Molecular and Cellular Endocrinology 200 1-2 2003 67 80
14. M.E. Keith, E. Laporta, and J. Welsh Stable expression of human VDR in murine VDR-null cells recapitulates vitamin D mediated anti-cancer signaling Molecular Carcinogenesis 2013 10.1002/mc.21975 (Epub ahead of print)
15. M.E. Valrance, A.H. Brunet, and J. Welsh Vitamin D receptor-dependent inhibition of mammary tumor growth by EB1089 and ultraviolet radiation in vivo Endocrinology 148 10 2007 4887 4894
16. J.M. Matilainen, M. Malinen, M.M. Turunen, C. Carlberg, and S. Vaisanen The number of vitamin D receptor binding sites defines the different vitamin D responsiveness of the CYP24 gene in malignant and normal mammary cells Journal of Biological Chemistry 285 31 2010 24174 24183
17. J.I. Herschkowitz, K. Simin, and V.J. Weigman et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors Genome Biology 8 5 2007 R76
18. B.D. Lehmann, J.A. Bauer, and X. Chen et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies Journal of Clinical Investigation 121 7 2011 2750 2767
19. S.P. Xie, G. Pirianov, and K.W. Colston Vitamin D analogues suppress IGF-I signalling and promote apoptosis in breast cancer cells European Journal of Cancer (Oxford, England: 1990) 35 12 1999 1717 1723
20. S.L. Maund, W.W. Barclay, and L.D. Hover et al. Interleukin-1alpha mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells Cancer Research 71 15 2011 5276 5286
21. T.T. Wang, L.E. Tavera-Mendoza, and D. Laperriere et al. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes Molecular Endocrinology (Baltimore, MD) 19 11 2005 2685 2695
22. A.E. Handel, G.K. Sandve, and G. Disanto et al. Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune disease BMC Medicine 11 2013 163
23. J. Satoh, and H. Tabunoki Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes Multiple Sclerosis (Houndmills, Basingstoke, England) 19 8 2013 1035 1045
24. S. Heikkinen, S. Vaisanen, P. Pehkonen, S. Seuter, V. Benes, and C. Carlberg Nuclear hormone 1alpha,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy Nucleic Acids Research 39 21 2011 9181 9193
25. M.B. Meyer, P.D. Goetsch, and J.W. Pike A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha,25-dihydroxyvitamin D3 Journal of Biological Chemistry 285 20 2010 15599 15610
26. W.L. Wang, N. Chatterjee, S.V. Chittur, J. Welsh, and M.P. Tenniswood Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells Molecular Cancer 10 2011 58
27. R. Kasiappan, Z. Shen, and A.K. Tse et al. 1,25-Dihydroxyvitamin D3 suppresses telomerase expression and human cancer growth through microRNA-498 Journal of Biological Chemistry 287 49 2012 41297 41309
28. T.S. Lisse, J.S. Adams, and M. Hewison Vitamin D and microRNAs in bone Critical Reviews in Eukaryotic Gene Expression 23 3 2013 195 214
29. V. Dimitrov, R. Salehi-Tabar, B.S. An, and J.H. White Non-classical mechanisms of transcriptional regulation by the vitamin D receptor: insights into calcium homeostasis, immune system regulation and cancer chemoprevention Journal of Steroid Biochemistry and Molecular Biology 2013 10.1016/j.jsbmb.2013. 07.012 pii: S0960-0760(13)00141-6, (Epub ahead of print)
30. I.S. Mathiasen, I.N. Sergeev, L. Bastholm, F. Elling, A.W. Norman, and M. Jaattela Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells Journal of Biological Chemistry 277 34 2002 30738 30745
31. E.J. Gallagher, N. Alikhani, and A. Tobin-Hess et al. Insulin receptor phosphorylation by endogenous insulin or the insulin analog AspB10 promotes mammary tumor growth independent of the IGF-1 receptor Diabetes 62 10 2013 3553 3560 10.2337/db13-0249 pii: S0960-0760(13)00141-6, (Epub)
32. A. Umar, H. Kang, and A.M. Timmermans et al. Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer Molecular & Cellular Proteomics: MCP 8 6 2009 1278 1294
33. W.M. Lau, M. Doucet, R. Stadel, D. Huang, K.L. Weber, and S.L. Kominsky Enpp1: A potential facilitator of breast cancer bone metastasis PLoS ONE 8 7 2013 e66752
34. H. Noh, S. Hong, and S. Huang Role of urokinase receptor in tumor progression and development Theranostics 3 7 2013 487 495
35. C.M. Ghajar, H. Peinado, and H. Mori et al. The perivascular niche regulates breast tumour dormancy Nature Cell Biology 15 7 2013 807 817
36. D. Xu, H. Xu, and Y. Ren et al. Cancer stem cell-related gene periostin: A novel prognostic marker for breast cancer PLoS ONE 7 10 2012 e46670
37. Z. Wang, and G. Ouyang Periostin: A bridge between cancer stem cells and their metastatic niche Cell Stem Cell 10 2 2012 111 112
38. I. Malanchi, A. Santamaria-Martinez, and E. Susanto et al. Interactions between cancer stem cells and their niche govern metastatic colonization Nature 481 7379 2012 85 89
39. L. Morra, and H. Moch Periostin expression and epithelial-mesenchymal transition in cancer: A review and an update Virchows Archiv: An International Journal of Pathology 459 5 2011 465 475
40. C.S. Schuetz, M. Bonin, and S.E. Clare et al. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis Cancer Research 66 10 2006 5278 5286
41. H. Okuda, A. Kobayashi, and B. Xia et al. Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells Cancer Research 72 2 2012 537 547
42. L. Udabage, G.R. Brownlee, S.K. Nilsson, and T.J. Brown The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer Experimental Cell Research 310 1 2005 205 217
43. H. Urakawa, Y. Nishida, and J. Wasa et al. Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo International Journal of Cancer Journal International du Cancer 130 2 2012 454 466
44. B. Bernert, H. Porsch, and P. Heldin Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1) Journal of Biological Chemistry 286 49 2011 42349 42359
45. Y. Li, L. Li, T.J. Brown, and P. Heldin Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells International Journal of Cancer Journal International du Cancer 120 12 2007 2557 2567
46. P.D. Bos, X.H. Zhang, and C. Nadal et al. Genes that mediate breast cancer metastasis to the brain Nature 459 7249 2009 1005 1009
47. J. Monslow, N. Sato, J.A. Mack, and E.V. Maytin Wounding-induced synthesis of hyaluronic acid in organotypic epidermal cultures requires the release of heparin-binding egf and activation of the EGFR Journal of Investigative Dermatology 129 8 2009 2046 2058
48. G. Kaya, C. Tran, and O. Sorg et al. Hyaluronate fragments reverse skin atrophy by a CD44-dependent mechanism PLoS Medicine 3 12 2006 e493
49. L. Barnes, C. Tran, and O. Sorg et al. Synergistic effect of hyaluronate fragments in retinaldehyde-induced skin hyperplasia which is a Cd44-dependent phenomenon PLoS ONE 5 12 2010 e14372
50. G.D. Richardson, H. Bazzi, and K.A. Fantauzzo et al. KGF and EGF signalling block hair follicle induction and promote interfollicular epidermal fate in developing mouse skin Development (Cambridge, England) 136 13 2009 2153 2164